JP2016525099A5 - 免疫グロブリンFc断片のFcRnに対する結合親和力が維持される免疫グロブリンFc結合体 - Google Patents

免疫グロブリンFc断片のFcRnに対する結合親和力が維持される免疫グロブリンFc結合体 Download PDF

Info

Publication number
JP2016525099A5
JP2016525099A5 JP2016525294A JP2016525294A JP2016525099A5 JP 2016525099 A5 JP2016525099 A5 JP 2016525099A5 JP 2016525294 A JP2016525294 A JP 2016525294A JP 2016525294 A JP2016525294 A JP 2016525294A JP 2016525099 A5 JP2016525099 A5 JP 2016525099A5
Authority
JP
Japan
Prior art keywords
immunoglobulin
fcrn
conjugates
fragments
retain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016525294A
Other languages
English (en)
Other versions
JP2016525099A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2014/006328 external-priority patent/WO2015005747A1/ko
Publication of JP2016525099A publication Critical patent/JP2016525099A/ja
Publication of JP2016525099A5 publication Critical patent/JP2016525099A5/ja
Pending legal-status Critical Current

Links

JP2016525294A 2013-07-12 2014-07-14 FcRn結合力が維持される免疫グロブリンFc結合体 Pending JP2016525099A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20130082509 2013-07-12
KR10-2013-0082509 2013-07-12
PCT/KR2014/006328 WO2015005747A1 (ko) 2013-07-12 2014-07-14 FcRn 결합력이 유지되는 면역글로불린 Fc 결합체

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020078005A Division JP6880278B2 (ja) 2013-07-12 2020-04-27 免疫グロブリンFc断片のFcRnに対する結合親和力が維持される免疫グロブリンFc結合体

Publications (2)

Publication Number Publication Date
JP2016525099A JP2016525099A (ja) 2016-08-22
JP2016525099A5 true JP2016525099A5 (ja) 2017-08-31

Family

ID=52280325

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016525294A Pending JP2016525099A (ja) 2013-07-12 2014-07-14 FcRn結合力が維持される免疫グロブリンFc結合体
JP2020078005A Active JP6880278B2 (ja) 2013-07-12 2020-04-27 免疫グロブリンFc断片のFcRnに対する結合親和力が維持される免疫グロブリンFc結合体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020078005A Active JP6880278B2 (ja) 2013-07-12 2020-04-27 免疫グロブリンFc断片のFcRnに対する結合親和力が維持される免疫グロブリンFc結合体

Country Status (22)

Country Link
US (2) US20160152684A1 (ja)
EP (1) EP3020732B1 (ja)
JP (2) JP2016525099A (ja)
KR (2) KR101872559B1 (ja)
CN (2) CN116082528A (ja)
AR (1) AR096890A1 (ja)
AU (1) AU2014287879B2 (ja)
CA (1) CA2917838C (ja)
DK (1) DK3020732T3 (ja)
EA (1) EA034297B1 (ja)
ES (1) ES2799326T3 (ja)
HK (1) HK1221957A1 (ja)
HU (1) HU231424B1 (ja)
IL (1) IL243567B (ja)
MX (1) MX2016000344A (ja)
MY (1) MY180374A (ja)
NO (1) NO20160182A1 (ja)
PH (1) PH12016500111A1 (ja)
PT (1) PT3020732T (ja)
TW (1) TWI693236B (ja)
UA (1) UA119644C2 (ja)
WO (1) WO2015005747A1 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20130049671A (ko) 2011-11-04 2013-05-14 한미사이언스 주식회사 생리활성 폴리펩타이드 결합체 제조 방법
AR090281A1 (es) 2012-03-08 2014-10-29 Hanmi Science Co Ltd Proceso mejorado para la preparacion de un complejo polipeptidico fisiologicamente activo
SG10202107752PA (en) * 2014-03-31 2021-09-29 Hanmi Pharmaceutical Co Ltd Method for improving solubility of protein and peptide by using immunoglobulin fc fragment linkage
AR107483A1 (es) 2016-01-29 2018-05-02 Hanmi Pharm Ind Co Ltd Conjugado de enzimas terapéuticas
US20190352335A1 (en) * 2016-12-19 2019-11-21 Hanmi Pharm. Co., Ltd. Brain targeting long-acting protein conjugate
WO2021010531A1 (ko) * 2019-07-18 2021-01-21 한미약품 주식회사 단백질 결합체의 신규 제조 방법
KR102382593B1 (ko) * 2020-01-29 2022-04-05 고려대학교 산학협력단 pH-감응성 Fc 변이체

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6030613A (en) * 1995-01-17 2000-02-29 The Brigham And Women's Hospital, Inc. Receptor specific transepithelial transport of therapeutics
US6096871A (en) 1995-04-14 2000-08-01 Genentech, Inc. Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life
WO1997034631A1 (en) 1996-03-18 1997-09-25 Board Of Regents, The University Of Texas System Immunoglobin-like domains with increased half lives
UA91325C2 (ru) * 2002-12-26 2010-07-26 Маунтин Вью Фармасьютикалз, Инк. Полимерные конъюгаты цитокинов, хемокинов, факторов роста, полипептидных гормонов и их антагонистов с сохраненной активностью рецепторного связывания
US20050176108A1 (en) * 2003-03-13 2005-08-11 Young-Min Kim Physiologically active polypeptide conjugate having prolonged in vivo half-life
BRPI0406605B8 (pt) * 2003-11-13 2021-05-25 Hanmi Holdings Co Ltd conjugado de proteína, método para a preparação do mesmo e composição farmacêutica para intensificar a duração e estabilidade in vivo de um polipeptídeo fisiologicamente ativo
KR100609434B1 (ko) 2004-12-30 2006-08-03 한국항공우주연구원 트랜스버살 필터
KR100754667B1 (ko) * 2005-04-08 2007-09-03 한미약품 주식회사 비펩타이드성 중합체로 개질된 면역글로불린 Fc 단편 및이를 포함하는 약제학적 조성물
US7625564B2 (en) * 2006-01-27 2009-12-01 Novagen Holding Corporation Recombinant human EPO-Fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo
JP2008169195A (ja) * 2007-01-05 2008-07-24 Hanmi Pharmaceutical Co Ltd キャリア物質を用いたインスリン分泌ペプチド薬物結合体
KR20080098216A (ko) * 2007-05-04 2008-11-07 한미약품 주식회사 캐리어 물질을 이용한 나트륨 배설 펩타이드 약물 결합체
WO2008147143A2 (en) * 2007-05-30 2008-12-04 Postech Academy-Industry Foundation Immunoglobulin fusion proteins
JP2009019027A (ja) 2007-07-16 2009-01-29 Hanmi Pharmaceutical Co Ltd アミノ末端のアミノ酸が変異したインスリン分泌ペプチド誘導体
AR072596A1 (es) * 2008-07-23 2010-09-08 Hanmi Pharmaceutical Co Ltd Un complejo proteico que comprende una proteina dimerica y un polimero no peptidico
CN102844332B (zh) * 2010-03-11 2015-08-19 瑞纳神经科学公司 呈pH依赖性抗原结合的抗体
AR081066A1 (es) * 2010-04-02 2012-06-06 Hanmi Holdings Co Ltd Conjugado de insulina donde se usa un fragmento de inmunoglobulina
KR101333958B1 (ko) * 2010-10-20 2013-11-27 주식회사 한독 인간 인터루킨-1 수용체 길항제-하이브리드 Fc 융합단백질
UA113626C2 (xx) * 2011-06-02 2017-02-27 Композиція для лікування діабету, що містить кон'югат інсуліну тривалої дії та кон'югат інсулінотропного пептиду тривалої дії
ES2968043T3 (es) 2011-06-10 2024-05-06 Hanmi Science Co Ltd Nuevos derivados de oxintomodulina y composición farmacéutica para el tratamiento de la obesidad que comprende la misma
KR101577734B1 (ko) * 2011-06-17 2015-12-29 한미사이언스 주식회사 옥신토모듈린과 면역글로불린 단편을 포함하는 결합체 및 그의 용도
BR112014005091A2 (pt) * 2011-09-05 2017-06-13 Beijing Hanmi Pharmaceutical Co Ltd composição farmacêutica para o tratamento do câncer compreendendo conjugado de interferon alfa
KR20130049671A (ko) * 2011-11-04 2013-05-14 한미사이언스 주식회사 생리활성 폴리펩타이드 결합체 제조 방법
KR102041412B1 (ko) * 2011-12-30 2019-11-11 한미사이언스 주식회사 면역글로불린 Fc 단편 유도체

Similar Documents

Publication Publication Date Title
HK1252863A1 (zh) 結合cd22的抗體分子
DK3221347T3 (da) Muterede immunoglobulin-bindende polypeptider
HK1252862A1 (zh) 結合cd45的抗體分子
ZA201701810B (en) Sirp-alpha immunoglobulin fusion proteins
MA43259A (fr) Liants ctla4
DK3143042T3 (da) Forbedrede variable immunoglobulindomæner
DK3242892T3 (da) Modificerede april-bindende antistoffer
RS62857B1 (sr) Unapređeni varijabilni domeni imunoglobulina koji vezuju serumski albumin
DK3137504T3 (da) Antistofbinding til fcrn til behandling af autoimmunsygdomme
DK3116486T3 (da) Hybrid immunoglobulin indeholdende ikke-peptidylbinding
IL281755A (en) Enhanced variable complexes of immunoglobulins
JP2016525099A5 (ja) 免疫グロブリンFc断片のFcRnに対する結合親和力が維持される免疫グロブリンFc結合体
DK3166970T3 (da) FORBEDREDE Aß-PROTOFIBRILBINDENDE ANTISTOFFER
DK3455244T3 (da) Muterede immunoglobulin-bindende polypeptider
DK3253785T3 (da) Hidtil ukendte egfr-bindingsproteiner
ZA201701941B (en) Antigen binding proteins that bind cxcr3
TH1601002706A (th) แอนทิบอดีที่จำเพาะต่อ FcRn